Details for New Drug Application (NDA): 203146
✉ Email this page to a colleague
The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 203146
Tradename: | RIZATRIPTAN BENZOATE |
Applicant: | Macleods Pharms Ltd |
Ingredient: | rizatriptan benzoate |
Patents: | 0 |
Pharmacology for NDA: 203146
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 203146
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 203146 | ANDA | Macleods Pharmaceuticals Limited | 33342-093 | 33342-093-04 | 12 TABLET, ORALLY DISINTEGRATING in 1 CONTAINER (33342-093-04) |
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 203146 | ANDA | Macleods Pharmaceuticals Limited | 33342-093 | 33342-093-07 | 30 TABLET, ORALLY DISINTEGRATING in 1 CONTAINER (33342-093-07) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Sep 19, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Sep 19, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription